title: [Patient's care and management of dyslipidemia at discharge after an acute coronary syndrome in the clinical practice in Spain: The SINCOPA study].
abstract: BACKGROUND
  European guidelines acknowledge that patients with an acute coronary syndrome (ACS) should have LDLc levels below 70mg/dL or reduced a 50% respect to their basal levels. However, some studies demonstrated that this goal is achieved in a small number of patients. The aim of this study was to determine how cardiologists (MC) and primary care specialist (GPs) from Spain manage LDLc in ACS patients during their daily practice.
  
  
  METHODS
  An observational, cross-sectional, multicentric study was conducted. Information about daily practice was obtained from 291 MC and 564 GPs across Spain.
  
  
  RESULTS
  68% of MC and 67% of GPs considered ACS patients to be high-risk. Most consider the cLDL targets based on European guidelines. The statins most widely used for MC are atorvastatin and rosuvastatina and for GPs are atorvastatin and simvastatin. 66.4% of GPs follow the prescription of MC. 42% of MC and 19.9% of GPs considered that 75-100% of their patients achieved the LDLc target. The main reason of not achieving this target was lack of treatment adherence.
  
  
  CONCLUSIONS
  The lack of adherence and poor perception of real LDLc control may contribute to the failure in achieving lipid targets in ACS patients.
authors.affiliation: Hospital Universitario de Basurto, Bilbao, España.
authors.forename: Nekane
authors.initials: N
authors.lastname: Murga
authors.affiliation: Departamento Médico, Ferrer Internacional, Barcelona, España.
authors.forename: Emilio
authors.initials: E
authors.lastname: Ruiz
authors.affiliation: Centro Salud Palleter, Castellón, España. Electronic address: pascual_vic@gva.es.
authors.forename: Vicente
authors.initials: V
authors.lastname: Pascual
mesh_terms: D054058:Acute Coronary Syndrome / Q000097:blood / Q000188:drug therapy*; D008078:Cholesterol, LDL / Q000097:blood*; D003430:Cross-Sectional Studies; D050171:Dyslipidemias / Q000188:drug therapy*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008055:Lipids / Q000097:blood; D055118:Medication Adherence; D005791:Patient Care / Q000379:methods; D010351:Patient Discharge; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data; D012307:Risk Factors; D013030:Spain
chemical_list: D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008055:Lipids
keywords: Acute coronary syndrome; Adherence; Adherencia; Control LDL; LDL control; Síndrome coronario agudo